SCHEMBL19212277

SCHEMBL19212277

Cc1cc(N2CCN(C(=O)O)CC2)ccc1CCN

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.45
GAA P10253 3/20 0.45
GFER P55789 2/20 0.43
ALDH1A1 P00352 2/20 0.43
RORC P51449 2/20 0.42
CASP6 P55212 1/20 0.42
CNR1 P21554 1/20 0.41
CNR2 P34972 1/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41
LMNA P02545 2/20 0.41
POLB P06746 1/20 0.41
RAD52 P43351 1/20 0.40
TSHR P16473 1/20 0.39
HTR1A P08908 4/20 0.39
HTR1D P28221 4/20 0.39
KDM4E B2RXH2 1/20 0.39
DPP4 P27487 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22957459 0.83 MAPT (0.51) MAPTALDH1A1MAPK1HTTLMNA
SCHEMBL19212196 0.80 MAPT (0.44) MAPTGAAGFERALDH1A1RORC
SCHEMBL19212260 0.80 MAPT (0.50) MAPTGAAALDH1A1CNR1CNR2
SCHEMBL2021224 0.79 MAPT (0.66) MAPTGAAGFERALDH1A1CASP6
SCHEMBL28747907 0.79 MAPT (0.50) MAPTGAAGFERALDH1A1MAPK1
SCHEMBL11299225 0.79 GAA (0.59) MAPTGAAGFERALDH1A1CASP6
SCHEMBL15265036 0.77 GRIN2B (0.51) MAPTGFERALDH1A1LMNAKDM4E
SCHEMBL19212275 0.77 ADRB1 (0.61) MAPTGAAHTTRAD52HTR1A
SCHEMBL17801223 0.77 MAPT (0.51) MAPTGAAGFERALDH1A1CASP6
SCHEMBL19212222 0.77 ME2 (0.50) MAPTGAAGFERALDH1A1CASP6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3414252-A1 THIENOPYRIDINE CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS Forma Therapeutics, Inc. (US) 2018-12-19 EP disclosed
WO-2017139778-A1 THIENOPYRIDINE CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS FORMA THERAPEUTICS, INC. (US) 2017-08-17 WO disclosed